12 research outputs found
Formation of Concentrated Nanoemulsion by W/O Microemulsion Dilution Method: Biodiesel, Tween 80, and Water System
In this work, we show the formation
of concentrated green O/W nanoemulsion
(dispersed phase mass fraction was up to 0.5) by diluting W/O microemulsion
in the water/Tween 80/biodiesel system. The mechanism of the formation
of nanoemulsions was examined and illustrated by small-angle X-ray
scattering (SAXS) and cryogenic transmission electron microscopy (cryo-TEM).
At high temperature, nanosized droplets formed spontaneously due to
the surfactant migration and inversion upon dilution of W/O microemulsions,
but these droplets were highly unstable. When cooled to room temperature,
their stability was highly enhanced due to the decrease of collision
frequency rate and the enhancement of stabilization of the oil/water
interface. Even though, the Ostwald ripening still results in growth
of droplets of the nanoemulsions after long-term storage, which limits
the practical applications of nanoemulsions. W/O microemulsions are
thermodynamic systems. Hence, W/O microemulsions that can form nanoemulsions
by simple dilution of water can be used as an alternative to O/W nanoemulsion
during storage and transport. Furthermore, biodiesel nanoemulsions
could meet the requirements of green chemistry and engineering and
be used as new green lubricants in water-based drilling fluid
Computational Study of Methane CβH Activation by Diiminopyridine Nitride/Nitridyl Complexes of 3d Transition Metals and Main-Group Elements
The CβH bond activation of
methane using <sup>Ph,Me</sup>PDIβMβ‘N [<sup>Ph,Me</sup>PDI = 2,6-(PhNξ»CMe)<sub>2</sub>C<sub>5</sub>H<sub>3</sub>N]
(M = V, Mn, Fe, Co, Ni, Al, or P) has been studied via three reaction
pathways: [2<sub>Ο</sub> + 2<sub>Ο</sub>] addition, hydrogen
atom abstraction (HAA), and direct insertion. The activating ligand
is a nitride/nitridyl (N), with diiminopyridine (PDI) as the supporting
ligand. Calculations show reasonable CβH activation barriers
for Co, Ni, Al, and P <sup>Ph,Me</sup>PDI nitrides, complexes that
favor an HAA pathway. Electrophilic <sup>Ph,Me</sup>PDI nitride complexes
of the earlier metals with a nucleophilic actor ligandξΈV, Mn,
FeξΈfollow a [2<sub>Ο</sub> + 2<sub>Ο</sub>] addition
pathway for methane activation. Free energy barriers for methyl migration, <sup>Ph,Me</sup>PDIβMΒ(CH<sub>3</sub>)ξ»NH β <sup>Ph,Me</sup>PDIβMβNΒ(H)ΒCH<sub>3</sub>, are also interesting in the
context of alkane functionalization; discriminating factors in this
mechanistic step include the strengths of the Ο-bond and metal-actor
ligand Ο-bond that are broken and the electrophilicity of the
actor ligand to which methyl migrates
Computational Study of Methane CβH Activation by Diiminopyridine Nitride/Nitridyl Complexes of 3d Transition Metals and Main-Group Elements
The CβH bond activation of
methane using <sup>Ph,Me</sup>PDIβMβ‘N [<sup>Ph,Me</sup>PDI = 2,6-(PhNξ»CMe)<sub>2</sub>C<sub>5</sub>H<sub>3</sub>N]
(M = V, Mn, Fe, Co, Ni, Al, or P) has been studied via three reaction
pathways: [2<sub>Ο</sub> + 2<sub>Ο</sub>] addition, hydrogen
atom abstraction (HAA), and direct insertion. The activating ligand
is a nitride/nitridyl (N), with diiminopyridine (PDI) as the supporting
ligand. Calculations show reasonable CβH activation barriers
for Co, Ni, Al, and P <sup>Ph,Me</sup>PDI nitrides, complexes that
favor an HAA pathway. Electrophilic <sup>Ph,Me</sup>PDI nitride complexes
of the earlier metals with a nucleophilic actor ligandξΈV, Mn,
FeξΈfollow a [2<sub>Ο</sub> + 2<sub>Ο</sub>] addition
pathway for methane activation. Free energy barriers for methyl migration, <sup>Ph,Me</sup>PDIβMΒ(CH<sub>3</sub>)ξ»NH β <sup>Ph,Me</sup>PDIβMβNΒ(H)ΒCH<sub>3</sub>, are also interesting in the
context of alkane functionalization; discriminating factors in this
mechanistic step include the strengths of the Ο-bond and metal-actor
ligand Ο-bond that are broken and the electrophilicity of the
actor ligand to which methyl migrates
mRNA expression of Slug in HS and normal skin tissues.
<p>mRNA expression of Slug was increased in HS (β=β0.76, <i>s</i>β=β0.13, <i>n</i>β=β4) compared to normal skin (β=β0.38, <i>s</i>β=β0.04, <i>n</i>β=β5) (A) and (B). Similar to the change of Slug mRNA level, western blot (C) and graphic analysis (D) showed that Slug was significantly increased in HS (β=β0.84, <i>s</i>β=β0.22, <i>n</i>β=β4) than that in normal skin (β=β0.42, <i>s</i>β=β0.18, <i>n</i>β=β5). * <i>P</i><0.01.</p
Quantitative RT-PCR analysis of COL1 and COL3 mRNA expressions
<p>. The mRNA levels of COL1 (A) and COL3 (B) in normal skin fibroblasts (β=β0.24, <i>s</i>β=β0.06; β=β0.28, <i>s</i>β=β0.05, respectively) were significantly lower, compared with other three groups. However, there is no significant difference in mRNA levels of COL1 (A) and COL3 (B) in HSFBs transfected with Slug shRNA (β=β0.82, <i>s</i>β=β0.08; β=β0.78, <i>s</i>β=β0.12, respectively), compared with non-transfected HSFBs (β=β0.95, <i>s</i>β=β0.17; β=β0.85, <i>s</i>β=β0.08, respectively) and HSFBs transfected with control shRNA (β=β0.80, <i>s</i>β=β0.11; β=β0.92, <i>s</i>β=β0.14, respectively), suggesting Slug shRNA had no effect on the collagen proteins synthesis in HS formation. *: <i>P</i><0.01 versus Slug shRNA; <sup>β </sup>: <i>P</i><0.01 versus Control shRNA; <sup>β‘</sup>: <i>P</i><0.01 versus HSFBs.</p
Expression of Slug in HSFBs and normal skin fibroblasts.
<p>Nuclear positive Slug was significantly higher in HSFBs (B, β=β51.73, <i>s</i>β=β3.74, <i>n</i>β=β38) than that in normal skin fibroblasts (A, β=β22.91, <i>s</i>β=β3.33, <i>n</i>β=β22). (C) Staining analysis of Slug in HS and normal skin. Scale bar: 20 Β΅m (A and B). * <i>P</i><0.01.</p
Effects of Slug shRNA on the expression of apoptosis-relative genes in HSFBs.
<p>The mRNA expression of Bcl-2 is decreased in HSFBs transfected with Slug shRNA (β=β0.23, <i>s</i>β=β0.03) than those in other groups. HSFBs transfected with control shRNA (β=β0.68, <i>s</i>β=β0.10) and non-transfected HSFBs (β=β0.70, <i>s</i>β=β0.06) expressed the most increased level of Bcl-2 than that in normal skin fibroblasts (β=β0.38, <i>s</i>β=β0.05) and HSFBs transfected with Slug shRNA (β=β0.23, <i>s</i>β=β0.03) (A and B). Similar with mRNA expression level, the protein expression of Bcl-2 is most decreased in Slug shRNA group (β=β0.24, <i>s</i>β=β0.06) and most increased in control shRNA (β=β0.96, <i>s</i>β=β0.07) and non-transfected group (β=β0.90, <i>s</i>β=β0.15) (C and D). Expression of Bax and PUMA at mRNA and protein level was detected in all groups. The mRNA level of Bax and PUMA was similar among the four groups (A and B). Similarly, western blot (C) and graphic analysis (D) showed that Bax and PUMA were similar in all groups.*: <i>P</i><0.01 versus Normal skin fibroblast; <sup>β </sup>: <i>P</i><0.01 versus Control shRNA; <sup>β‘</sup>: <i>P</i><0.01 versus HSFBs.</p
Effects of SFRP2 shRNA on the protein expression of SFRP2 and Slug in HSFBs.
<p>The SFRP2 protein level was significantly increased and decreased in the non- transfected HSFBs (β=β1.06, <i>s</i>β=β0.15) and the SFRP2 shRNA group (β=β0.14, <i>s</i>β=β0.02), respectively, compared with the normal skin fibroblasts (β=β0.36, <i>s</i>β=β0.05). And the protein expression of SFRP2 in HSFBs transfected with control shRNA (β=β0.90, <i>s</i>β=β0.06) was not significantly decreased than that in non-transfected HSFBs. After the treatments of the shRNAs, the SFRP2 protein level was significantly lower than that in the HSFBs and the HSFBs transfected with control shRNA (A and B). Similar to the effects on the expression of SFRP2, Slug expression was significantly higher in the non- transfected HSFBs and HSFBs transfected with control shRNA than that in normal skin fibroblasts both in mRNA (β=β0.70, <i>s</i>β=β0.08; β=β0.63, <i>s</i>β=β0.10; β=β0.37, <i>s</i>β=β0.05, respectively) and protein levels (β=β0.90, <i>s</i>β=β0.04; β=β0.84, <i>s</i>β=β0.11; β=β0.43, <i>s</i>β=β0.04, respectively). Moreover, both the Slug mRNA and protein levels were significantly decreased in HSFBs transfected with SFRP2 shRNA (β=β0.20, <i>s</i>β=β0.06; β=β0.25, <i>s</i>β=β0.05, respectively) compared with the non- transfected HSFBs and HSFBs transfected with control shRNA (B- F). *: <i>P</i><0.01 versus Normal skin fibroblast; <sup>β </sup>: <i>P</i><0.01 versus Control shRNA; <sup>β‘</sup>: <i>P</i><0.01 versus HSFBs.</p
Effects of Slug shRNA on the protein expression of Slug in HSFBs.
<p>The Slug protein level was significantly decreased in the HSFBs of the Slug shRNA group (β=β0.26, <i>s</i>β=β0.05), compared with the normal skin fibroblasts (β=β0.46, <i>s</i>β=β0.04), HSFBs transfected with control shRNA (β=β0.86, <i>s</i>β=β0.10) and non-transfected HSFBs (β=β0.92, <i>s</i>β=β0.04). And the protein expression of Slug in HSFBs transfected with control shRNA was not significantly decreased than that in non-transfected HSFBs. And the Slug protein level was significantly lower in normal skin fibroblast than that in non-transfected HSFBs and HSFBs transfected with control shRNA (A and B). *: <i>P</i><0.01 versus Normal skin fibroblast; <sup>β </sup>: <i>P</i><0.01 versus Control shRNA; <sup>β‘</sup>: <i>P</i><0.01 versus HSFBs.</p